NPI: 1043397177 · MARINETTE, WI 54143 · Rehabilitation Clinic/Center · NPI assigned 11/01/2006
Authorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
| Authorized Official | RICHARDSON, KARA (SVP FINANCE) |
| NPI Enumeration Date | 11/01/2006 |
Other providers sharing the same authorized official: RICHARDSON, KARA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 60,209 | $1.20M |
| 2019 | 68,789 | $1.31M |
| 2020 | 50,005 | $1.20M |
| 2021 | 74,028 | $1.72M |
| 2022 | 75,260 | $1.58M |
| 2023 | 74,627 | $1.52M |
| 2024 | 50,545 | $1.14M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,139 | 12,677 | $1.01M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 12,193 | 10,693 | $956K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,092 | 7,810 | $956K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,739 | 5,447 | $663K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6,465 | 5,092 | $584K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 14,256 | 4,835 | $425K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,959 | 3,618 | $353K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,024 | 3,674 | $266K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,632 | 3,266 | $263K |
| 80053 | Comprehensive metabolic panel | 23,160 | 17,808 | $260K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,164 | 2,243 | $204K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8,197 | 6,477 | $197K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,034 | 3,499 | $153K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,976 | 1,820 | $150K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,817 | 1,109 | $150K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 31,010 | 22,645 | $149K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,579 | 1,401 | $142K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,704 | 4,325 | $138K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,711 | 1,572 | $131K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,305 | 1,177 | $114K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 802 | 775 | $95K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,489 | 2,196 | $90K |
| 83880 | 4,055 | 3,582 | $88K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,095 | 1,857 | $86K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,888 | 1,300 | $83K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,749 | 1,964 | $83K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7,746 | 5,840 | $81K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 905 | 526 | $77K |
| 84484 | 9,761 | 7,878 | $70K | |
| 71045 | Radiologic examination, chest; single view | 7,305 | 6,530 | $68K |
| 96375 | Therapeutic injection; each additional sequential IV push | 7,626 | 5,949 | $64K |
| 97161 | 1,640 | 1,494 | $63K | |
| 84145 | 3,935 | 3,484 | $56K | |
| 82077 | 2,716 | 2,228 | $52K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 781 | 728 | $52K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,973 | 1,846 | $51K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,657 | 1,318 | $48K |
| 83605 | 6,861 | 5,764 | $47K | |
| 97597 | 1,363 | 718 | $46K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,148 | 1,067 | $46K |
| 83735 | 12,151 | 8,758 | $45K | |
| 80061 | Lipid panel | 1,227 | 1,163 | $44K |
| 71046 | Radiologic examination, chest; 2 views | 2,588 | 2,437 | $37K |
| 84443 | Thyroid stimulating hormone (TSH) | 3,417 | 3,128 | $36K |
| G0378 | Hospital observation service, per hour | 2,912 | 2,144 | $36K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,672 | 4,148 | $36K |
| 81025 | 5,126 | 4,542 | $32K | |
| 83690 | 7,959 | 6,876 | $32K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 241 | 231 | $32K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 430 | 409 | $31K |
| 86850 | 1,498 | 1,292 | $29K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,402 | 1,288 | $28K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 882 | 466 | $24K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 898 | 860 | $23K |
| 85379 | 3,487 | 3,187 | $21K | |
| 87040 | 2,570 | 1,868 | $21K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 853 | 821 | $20K |
| 76830 | Ultrasound, transvaginal | 473 | 441 | $20K |
| 96367 | 539 | 346 | $19K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 251 | 231 | $19K |
| 85610 | 5,837 | 4,588 | $17K | |
| 82962 | 4,682 | 2,528 | $17K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 83 | 79 | $17K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,059 | 581 | $16K |
| 81001 | 7,317 | 6,481 | $16K | |
| 80076 | 2,482 | 2,217 | $15K | |
| 70496 | 134 | 126 | $15K | |
| 86900 | 1,552 | 1,338 | $15K | |
| 84702 | 618 | 435 | $15K | |
| 82728 | 1,166 | 1,046 | $13K | |
| 85730 | 3,770 | 3,311 | $12K | |
| 81003 | 4,600 | 4,124 | $12K | |
| 87081 | 554 | 522 | $11K | |
| 80143 | 1,070 | 886 | $11K | |
| 97162 | 286 | 276 | $11K | |
| 71250 | 286 | 263 | $11K | |
| 82607 | 702 | 653 | $10K | |
| 87077 | 1,218 | 1,101 | $10K | |
| 70498 | 144 | 136 | $10K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 53 | 50 | $10K |
| 80179 | 1,014 | 844 | $10K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 439 | 392 | $9K |
| 85027 | 1,972 | 1,428 | $9K | |
| 86140 | 2,639 | 2,295 | $9K | |
| 93971 | 227 | 207 | $9K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 285 | 269 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 285 | 269 | $8K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 742 | 706 | $8K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 152 | 146 | $8K |
| A0425 | Ground mileage, per statute mile | 199 | 153 | $7K |
| 82805 | 253 | 221 | $6K | |
| 87186 | 1,216 | 1,095 | $6K | |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 64 | 55 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | 809 | 748 | $5K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 282 | 261 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 482 | 453 | $5K |
| 80050 | General health panel | 366 | 320 | $5K |
| 85652 | 2,428 | 2,153 | $4K | |
| 0240U | 178 | 173 | $4K | |
| 90715 | 403 | 364 | $4K | |
| 74018 | 365 | 331 | $3K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 12 | 12 | $3K |
| 97165 | 101 | 98 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,291 | 3,670 | $3K |
| 86803 | 284 | 264 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 76 | 65 | $3K |
| 87340 | 381 | 356 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13,835 | 11,536 | $3K |
| 83550 | 564 | 514 | $3K | |
| 64493 | 13 | 13 | $3K | |
| 86901 | 1,553 | 1,338 | $3K | |
| 84439 | 331 | 306 | $2K | |
| 72141 | 26 | 26 | $2K | |
| 76770 | 24 | 24 | $2K | |
| 83540 | 638 | 582 | $2K | |
| 97113 | 48 | 24 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 41 | 39 | $2K |
| 12001 | 35 | 32 | $2K | |
| 82746 | 236 | 220 | $2K | |
| 84703 | 331 | 312 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 27 | 25 | $2K |
| 93017 | 101 | 89 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 55 | 40 | $2K |
| 87070 | 187 | 167 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 476 | 406 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 27 | 25 | $2K |
| 87807 | 85 | 82 | $1K | |
| 36415 | Collection of venous blood by venipuncture | 7,372 | 5,037 | $1K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 13 | 13 | $1K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 15 | 15 | $1K |
| 82550 | 356 | 297 | $1K | |
| 87088 | 288 | 270 | $1K | |
| 82565 | 164 | 142 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 24 | 12 | $1K |
| 83615 | 230 | 193 | $980.40 | |
| 64494 | 12 | 12 | $790.09 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,044 | 929 | $764.40 |
| 72100 | 115 | 109 | $761.11 | |
| 73630 | 326 | 301 | $653.27 | |
| 70486 | 19 | 16 | $640.74 | |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 33 | 26 | $631.92 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 7,350 | 6,464 | $612.30 |
| 73030 | 285 | 255 | $545.73 | |
| 73562 | 303 | 273 | $526.48 | |
| 73610 | 269 | 249 | $521.19 | |
| 87205 | 213 | 188 | $488.68 | |
| 86780 | 52 | 50 | $488.58 | |
| 82570 | 100 | 93 | $405.04 | |
| 96376 | 2,501 | 1,570 | $353.31 | |
| 73502 | 40 | 38 | $323.69 | |
| 86618 | 29 | 24 | $303.98 | |
| 84100 | 97 | 86 | $257.88 | |
| 82010 | 25 | 24 | $129.47 | |
| 73130 | 100 | 88 | $109.12 | |
| 86762 | 12 | 12 | $90.86 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 277 | 262 | $90.56 |
| 86787 | 14 | 13 | $90.28 | |
| 84156 | 29 | 28 | $84.47 | |
| 82272 | 47 | 41 | $75.99 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 6,927 | 5,834 | $73.48 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 935 | 735 | $57.87 |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,305 | 1,206 | $50.79 |
| 84134 | 17 | 15 | $39.25 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 13,122 | 10,213 | $39.13 |
| 86592 | 12 | 12 | $38.76 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,906 | 1,374 | $36.86 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,918 | 3,172 | $36.52 |
| 36410 | 133 | 120 | $15.62 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,613 | 2,105 | $8.10 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,243 | 1,077 | $5.78 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 6,916 | 5,550 | $5.62 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 438 | 387 | $4.53 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 15 | 12 | $1.52 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,506 | 1,166 | $1.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,030 | 1,257 | $0.67 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 478 | 392 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 3,655 | 1,738 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,434 | 1,171 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 3,072 | 2,555 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 1,938 | 1,434 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,330 | 2,033 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 1,219 | 444 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,022 | 2,321 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 23 | 12 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 401 | 78 | $0.00 |
| 36416 | 147 | 69 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 114 | 102 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 44 | 25 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 74 | 58 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 84 | 78 | $0.00 |
| 88304 | 12 | 12 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 13 | 12 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 13 | 12 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,439 | 1,040 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 162 | 140 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 992 | 847 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,074 | 960 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,220 | 931 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 979 | 809 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 26 | 25 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 114 | 84 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2,149 | 1,687 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 20 | 14 | $0.00 |
| C1776 | Joint device (implantable) | 14 | 12 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 264 | 180 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 521 | 481 | $0.00 |
| A4565 | Slings | 12 | 12 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 63 | 57 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 103 | 53 | $0.00 |
| 73140 | 12 | 12 | $0.00 | |
| 73110 | 18 | 18 | $0.00 |